SCHEMBL4908025

SCHEMBL4908025

CCN(c1ccc(OCc2cc(F)cc(F)c2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 3/20 0.42
MMP2 P08253 2/20 0.42
ADAM17 P78536 2/20 0.42
MMP14 P50281 1/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.39
GSK3B P49841 1/20 0.39
BACE1 P56817 1/20 0.39
KEAP1 Q14145 2/20 0.39
NFE2L2 Q16236 2/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MMP13 P45452 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR1 P03372 1/20 0.37
MAOB P27338 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904039 0.93 KEAP1 (0.47) MMP9MMP2ADAM17MMP14MAPT
SCHEMBL4906732 0.91 LMNA (0.47) MMP9MMP2ADAM17MMP14LMNA
SCHEMBL4906221 0.90 MMP9 (0.47) MMP9MMP2ADAM17MMP14MAPT
SCHEMBL4911874 0.89 MAOA (0.43) MMP9MMP2ADAM17MAPTLMNA
SCHEMBL4894413 0.86 MMP2 (0.49) MMP9MMP2MAPTKEAP1NFE2L2
SCHEMBL4906576 0.86 MMP2 (0.45) MMP9MMP2ADAM17MMP14MAPT
SCHEMBL4898047 0.85 MAPT (0.47) MMP9MMP2MAPTLMNAKMT2A
SCHEMBL4895665 0.84 LMNA (0.41) MAPTLMNAKEAP1NFE2L2ALDH1A1
SCHEMBL4900687 0.83 ESR1 (0.39) MMP9ADAM17MAPTLMNAKEAP1
SCHEMBL4897627 0.83 KEAP1 (0.48) MMP9MMP2ADAM17LMNAKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP9 4666/4885MMP2 4348/4885ADAM17 4821/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP9 4632/4885MMP2 4105/4885ADAM17 4813/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP9 4632/4885MMP2 4105/4885ADAM17 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.